Fred Hutch leaders helped shape recommendations that put patients first, promoting value, affordability, innovation
March 12, 2018
| By Sabin Russell / Fred Hutch News Service
The President's Cancer Panel, an independent advisory group, called for “urgent action” to address rapidly rising prices for cancer drugs and the burden cancer patients and their families face because of the high cost of cancer care.
A Fred Hutch researcher speaks out on the human cost of the ‘unfettered, unbridled greed’ within our health care system
Feb. 11, 2016
| By Dr. Gary Lyman, as told to Diane Mapes
As an oncologist, I've had patients delay or actually stop treatment because of the high cost. They're stopping and they're dying as a result. That's why I've taken a stand with many of my colleagues around the country to call attention to these pricing issues and how unsustainable and devastating they are to our patients.
Scott Ramsey study finds average insolvency rates rise fourfold within five years of cancer diagnosis
June 6, 2011
| By Kristen Woodward
An analysis led by Dr. Scott Ramsey of the Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance linking federal bankruptcy court records to cancer registry data from nearly 232,000 adult cancer cases in western Washington during a 14-year period has found a hidden cost to survival: Insolvency rates increase along with the length of survival.